Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Blood Component RemovalHematologic NeoplasmsStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideTreatment OutcomeGraft vs Host DiseaseMyeloablative AgonistsBusulfanGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinHematopoietic Stem CellsRemission InductionAntineoplastic Agents, AlkylatingRecurrenceEtoposideThiotepaSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideAmyloidosisBoronic AcidsRetrospective StudiesPyrazinesSurvival RateThalidomideStem CellsCytarabineHematopoiesisDexamethasoneHodgkin DiseaseCord Blood Stem Cell TransplantationTissue DonorsPrednisoneSurvival AnalysisTransplantation ChimeraDoxorubicinNeoplasmsTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsImmunosuppressive AgentsHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingBone MarrowFollow-Up StudiesCarboplatinTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone Marrow PurgingVidarabinePlasma CellsLeukemiaBlood Cell CountRecombinant ProteinsLymphomaCytomegalovirus InfectionsProspective StudiesPrognosisImmunophenotypingFatal OutcomeBlood CellsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsMyelodysplastic SyndromesFlow CytometryKidney TransplantationAnemia, AplasticParaproteinemiasBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBone Marrow CellsLiver TransplantationCyclosporineT-LymphocytesOpportunistic InfectionsHematologic DiseasesLeukocytes, Mononuclear